Cite

HARVARD Citation

    Fuh, F. et al. (2017). Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells. British journal of pharmacology. pp. 628-640. [Online]. 
  
Back to record